Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy. (2023)

First Author: Schnegg-Kaufmann AS
Attributed to:  Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2022018602

PubMed Identifier: 36493342

Publication URI: http://europepmc.org/abstract/MED/36493342

Type: Journal Article/Review

Volume: 141

Parent Publication: Blood

Issue: 11

ISSN: 0006-4971